You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

PIMOZIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Pimozide, and what generic alternatives are available?

Pimozide is a drug marketed by Endo Operations and is included in one NDA.

The generic ingredient in PIMOZIDE is pimozide. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pimozide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pimozide

A generic version of PIMOZIDE was approved as pimozide by ENDO OPERATIONS on September 28th, 2015.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PIMOZIDE?
  • What are the global sales for PIMOZIDE?
  • What is Average Wholesale Price for PIMOZIDE?
Drug patent expirations by year for PIMOZIDE
Drug Prices for PIMOZIDE

See drug prices for PIMOZIDE

Recent Clinical Trials for PIMOZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Food and Drug Administration (FDA)Phase 1
Spaulding Clinical Research LLCPhase 1
Jupiter Wellness, Inc.N/A

See all PIMOZIDE clinical trials

Pharmacology for PIMOZIDE
Medical Subject Heading (MeSH) Categories for PIMOZIDE
Anatomical Therapeutic Chemical (ATC) Classes for PIMOZIDE

US Patents and Regulatory Information for PIMOZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Endo Operations PIMOZIDE pimozide TABLET;ORAL 204521-001 Sep 28, 2015 RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Endo Operations PIMOZIDE pimozide TABLET;ORAL 204521-002 Sep 28, 2015 RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.